-
Events
Time
Topic
Speaker
8:30-8:45
Welcome
B. Mark Evers, MD
Director, Markey Cancer Center
University of KentuckyGeneral Session I: Assessment and Treatment of Solid Tumors
8:45-9:30
Keynote 1: Role of ETCTN in fostering cancer research in Appalachian Kentucky: Challenges and opportunities.
Charles Kunos, MD, PhD
Physician
Investigational Drug Branch, National Cancer Institute
Washington, DC- Discuss ETCTN sponsored clinical trial opportunities for Appalachian communities
9:30-10:15
Precision Treatment of Neuroendocrine Tumors
Aman Chauhan, MD
Assistant Professor of Medicine
University of KentuckyErica L. Takimoto, DO
Gynecologic oncologist
Norton Cancer Institute
Louisville, Kentucky- List new treatment options for neuroendocrine tumors
- Provide patient specific recommendations for managing neuroendocrine tumors
10:15-10:30
Assessment And Treatment Of Solid Tumors Overview And Discussion
Session I Speakers
Moderated by:
Discuss the various treatments of solid tumors and how it impacts patient care
10:30-11:00
Break
11:00-11:45
Workshop 1 (Participants pick one)
- Novel Surgical Strategies in GI Malignancies
Michael Cavnar, MD
Assistant Professor of Surgery
University of KentuckyJoseph Kim, MD
Chief of Surgical Oncology
University of Kentucky- Describe the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of GI cancers
- Discuss the role intraarterial chemotherapy to target metastatic liver lesions
- Implementing a Germline Precision Medicine Program
Brook Phillips, MD
Medical Oncologist
St. Elizabeth Healthcare
Edgewood, KYDan Flora, MD
Medical Oncologist
St. Elizabeth Healthcare
Edgewood, KY- Describe the role of CYP2D6 genotyping in the use of tamoxifen
- Discuss implementation strategies for common drug metabolizing agents and their use in oncology
- New Therapies for AML, Targeting FLT3 and IDH Mutations
Reshma Ramlal, MD
Assistant Professor of Medicine
University of Kentucky- Describe the place in therapy of hypomethylating agents, sorafenib, ivosidenib, and enasidenib
- Recognize and manage adverse effects associated with these agents
- Hot Topics: Gene Expression Prognostic Assays in Breast Cancer and Markers of Intratumoral Heterogeneity
Rachel Stewart, DO, PhD
Assistant Professor of Pathology and Laboratory Medicine
University of KentuckyTherese Bocklage, MD
Professor of Pathology and Laboratory Medicine
University of Kentucky- Discuss recent results from TailorRx trial
- Describe gene expression assays to assess prognosis in breast cancer
- Identify methods to assess intratumoral heterogeneity and its impact of clinical diagnostics
11:45-1:15
Lunch with Ongoing Clinical Trials Poster Session
1:15-2:00
Workshop 2 (Participants pick one)
Implementing a CAR T-Cell Therapeutic Program
Gerhardt Hildebrandt, MD, FACP
Professor of Medicine,
Division Chief, Hematology and Blood Marrow Transplantation
University of KentuckyAmber Lawson, PharmD
Assistant Professor, College of Pharmacy
University of KentuckyJennifer Christian
Division of Hematology and Blood Marrow Transplantation
Administrative Coordinator
UK HealthCare- Describe challenges and strategies to overcome them when implementing a CAR T-cell program
- Managing Combination Immunotherapies
John Villano, MD, PhD
Professor of Medicine
University of KentuckyRachael Morgan, PharmD
Hematology/Oncology Clinical Pharmacist
UK HealthCare- Describe common indications and adverse effects associated with combination immunotherapies and their management
- Panel: Inherited Cancer Syndromes
Rachel C. Miller, MD
Associate Professor of Obstetrics and Gynecology
University of KentuckyPeng Wang, MD,
Assistant Professor of Medicine
University of KentuckyJustine Cooper Pickarski, MS
Genetic Counselor Supervisor
University of Kentucky- Discuss recent updates for germline testing recommendations for ovarian, prostate and pancreas cancer
- Identify appropriate candidates for germline testing
- Describe mechanisms for genetic counselor referrals
- Novel Advances in Next Generation Sequencing
Shulin Zhang, MD, PhD
Professor of Pathology and Medicine
University of Kentuckya) Describe the recent advances in next generation sequencing technology
Role of NGS testing in Precision Management of Hematological Malignancies
Ranjana Arora, MD, MPH. FCAP
Assistant Professor of Pathology and Laboratory Medicine
Medical Director, Molecular Hematology Services
University of Kentucky- Discuss recent technology advances integral to precision medicine
- Explain and interpret NGS of hematological malignancies
2:00-2:30
Break
General Session II: Treatment Advances in Hematological Malignancies
2:30-3:00
Treatment Advances in CAR T-cells
Hayder Saeed, MD
Assistant Professor of Medicine
University of Kentucky
Jacob Hodskins, MD, MS
Oncologist
Owensboro Health Medical Group
Owensboro, Kentucky
- Explain a difficult relapsed case of diffuse large B cell lymphoma
- Describe recent clinical advances in CAR T-cell therapy
3:00-3:45
Keynote 2: The Future is Finally Here: Targeted Therapy in the Treatment of Acute Myeloid Leukemia
Eytan M. Stein, MD
Hematologic Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY
- Discuss place in therapy for targeted therapies for AML
3:45-4:00
Treatment Advances in Hematological Malignancies Overview and Discussion
Session II Speakers
Moderated by:
Firas Badin, MD
Physician
BHMG Hematology and Oncology
Lexington, Kentucky
Review the advance treatment of hematological malignancies, the benefits and its impact on patients and their care
4:00-4:30
Wrap-up
Menu
-
Patients & Visitors
- COVID-19
- Appointment
- UK Urgent TeleCare
- UK TeleCare
- Clinical Trials
- Conditions A-Z
- Contact Us
- Jacobs Health Education Center
- eGreetings
- Interpreter Services
- Medical Records
- Notice of Nondiscrimination
- Office of Patient Experience
- Payment & Insurance
- Policies
- Refill Prescription
- Subscribe to HealthMatters
- Thank a Great Nurse
- Patients & Visitors home
- Services
-
Hospitals & Clinics
- Parking
- Emergency Departments
- Albert B. Chandler Hospital
- Barnstable Brown Diabetes Center
- Eastern State Hospital
- Good Samaritan Hospital
- Gill Heart & Vascular Institute
- Kentucky Children's Hospital
- Kentucky Clinic
- Kentucky Neuroscience Institute
- Markey Cancer Center
- Transplant Center
- UK HealthCare Turfland
- Hospitals & Clinics home
- Wellness & Community
- Research
- For Providers
- About Us
- Give Now